TRCT
GOVX icon

Tower Research Capital (TRC)’s GeoVax Labs GOVX Stock Holding History

Tower Research Capital (TRC)’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Sell
3,502
-25
-0.7% -$38 ﹤0.01% 4385
2026
Q1 		$4.87K Buy
+3,527
New +$8.45K ﹤0.01% 4162
2025
Q3 		– Sell
-70
Closed -$1.51K – 5368
2025
Q2 		$1.51K Sell
70
-127
-64% -$3.17K ﹤0.01% 4801
2025
Q1 		$5.23K Buy
+197
New +$8.69K ﹤0.01% 4142
2024
Q4 		– Sell
-120
Closed -$7.21K – 5802
2024
Q3 		$7.21K Sell
120
-170
-59% -$14.3K ﹤0.01% 4068
2024
Q2 		$23.1K Buy
290
+111
+62% +$4.88K ﹤0.01% 3673
2024
Q1 		$8.94K Buy
179
+152
+563% +$12K ﹤0.01% 3926
2023
Q4 		$3.71K Sell
27
-1
-4% -$175 ﹤0.01% 5049
2023
Q3 		$5.4K Hold
28
– – ﹤0.01% 4725
2023
Q2 		$5.81K Sell
28
-1
-3% -$239 ﹤0.01% 4789
2023
Q1 		$7K Buy
29
+11
+61% +$3.09K ﹤0.01% 4739
2022
Q4 		$4K Buy
18
+17
+1,700% +$5.16K ﹤0.01% 5007
2022
Q3 		$0 Sell
1
-163
-99% -$93.9K ﹤0.01% 6222
2022
Q2 		$51K Buy
164
+148
+925% +$65.2K ﹤0.01% 2859
2022
Q1 		$7K Buy
+16
New +$12.7K ﹤0.01% 4721
2021
Q4 		– Sell
-3
Closed -$6K – 6295
2021
Q3 		$6K Buy
3
+2
+200% +$3.48K ﹤0.01% 4749
2021
Q2 		$3K Sell
1
-5
-83% -$9.72K ﹤0.01% 4919
2021
Q1 		$10K Buy
+6
New +$11.7K ﹤0.01% 4363

Other funds holding GOVX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Tower Research Capital (TRC)'s GOVX Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its GeoVax Labs (GOVX) stake by 0.71% in Q2 2026, selling an estimated $38 and leaving 3,502 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #4385.

Tower Research Capital (TRC) first reported a position in GOVX in Q1 2021 and has held it in 18 quarters since. The position peaked at $51K in Q2 2022. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • Tower Research Capital (TRC) held 3,502 shares of GeoVax Labs worth $4.45K as of Q2 2026.
  • Tower Research Capital (TRC) sold 25 GeoVax Labs shares in Q2 2026, an estimated $38.
  • GeoVax Labs made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4385 holding.
  • Tower Research Capital (TRC) first reported a position in GeoVax Labs in Q1 2021 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s GeoVax Labs position peaked at $51K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.